Accretive Health (AH +1.1%) gains after Raymond James initiated the stock with a Strong Buy...


Accretive Health (AH +1.1%) gains after Raymond James initiated the stock with a Strong Buy earlier today and a $16.00 price target. The firm notes four bullish components to AH's story: a shift from an information technology focus to to revenue cycle; a differentiated infused management model; margin expansion potential; and expectations for multiple expansion with its Minnesota litigation in the rearview mirror.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs